LLK203 is a potent USP2/USP8 dual-target inhibitor with IC50s of 0.89 µM and 0.52 µM, respectively. LLK203 leads a degradation of ERalpha and induces apoptosis of breast cancer MCF-7 cells. LLK203 demonstrates antitumor activities against the 4T1 tumor mice model[1].
Molecular Weight:
561.69
Purity:
98.58
CAS Number:
[2758090-62-7]
Formula:
C28H23N3O4S3
Target:
Apoptosis,Deubiquitinase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
